Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 261 to 270

APO-RALOXIFENE raloxifene hydrochloride 60 mg tablet blister Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-RALOXIFENE raloxifene hydrochloride 60 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-VALSARTAN valsartan 40 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-VALSARTAN valsartan 320 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-VALSARTAN valsartan 160 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS MELOXICAM meloxicam 15mg capsule blister pack. Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS MELOXICAM meloxicam 7.5mg capsule blister pack. Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART VENLAFAXINE XR venlafaxine (as hydrochloride) 150mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART VENLAFAXINE XR venlafaxine (as hydrochloride) 75mg modified release capsule blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
Apotex Pty Ltd - Earwax softening otic solution Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 23
Page 24
Page 25
Page 26
Current page 27
Page 28
Page 29
Page 30
Page 31
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.